Tag Archives: stack ranking

Rigid stack ranking of employee performance and pharmaceutical research is a bad combination

Posted on December 10, 2013 by

Microsoft’s recent decision to abandon employee stack ranking is just the latest example of the growing skepticism around stack ranking performance management schemes, especially ones that force bottom 5-10% distributions.  Sadly, some pharmaceutical firms still use the method. The major arguments against stack … Continue reading →

Posted in Fixing Big Pharma Research, Management | Tagged , , , , , | 1 Comment